- Filed
- Jan 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Jan 10, 2025 | 6.7M sh |
| Cash And Equivalents | Q3 2025 · Nov 30, 2024 | $1.24K |
| Cash And Equivalents | Q3 2025 · Feb 29, 2024 | $9.07K |
| Current Liabilities | Q3 2025 · Nov 30, 2024 | $89.48K |
| Current Liabilities | Q3 2025 · Feb 29, 2024 | $80K |
| Current Assets | Q3 2025 · Nov 30, 2024 | $33.24K |
| Current Assets | Q3 2025 · Feb 29, 2024 | $84.87K |
| Total Assets | Q3 2025 · Nov 30, 2024 | $95.47K |
| Total Assets | Q3 2025 · Feb 29, 2024 | $108.06K |
| Operating Income | Q3 2025 · Nov 30, 2024 | $22.07K |
| Operating Income | Q3 2025 · Nov 30, 2023 | $6.07K |
| Cost Of Revenue | Q3 2025 · Nov 30, 2024 | $8.84K |
| Cost Of Revenue | Q3 2025 · Nov 30, 2024 | $23.43K |
| Cost Of Revenue | Q3 2025 · Nov 30, 2023 | $3.29K |
| Cost Of Revenue | Q3 2025 · Nov 30, 2023 | $18.23K |
| Revenue | Q3 2025 · Nov 30, 2024 | $8.84K |
| Revenue | Q3 2025 · Nov 30, 2024 | $23.43K |
| Revenue | Q3 2025 · Nov 30, 2023 | $3.29K |
| Revenue | Q3 2025 · Nov 30, 2023 | $18.23K |
| Stock Issued restated | Q3 2025 · Nov 30, 2023 | 25K sh |
| Shares Diluted | Q3 2025 · Nov 30, 2023 | 5M sh |
| Shares Diluted | Q3 2025 · Nov 30, 2023 | 5M sh |
| Operating Cash Flow | Q3 2025 · Nov 30, 2023 | −$19.64K |
| Eps Diluted | Q3 2025 · Nov 30, 2023 | $0.00 |
| Eps Diluted | Q3 2025 · Nov 30, 2023 | $0.00 |
| Sga Expense | Q3 2025 · Nov 30, 2023 | $3.79K |
| Sga Expense | Q3 2025 · Nov 30, 2023 | $24.3K |
| Net Income | Q3 2025 · Nov 30, 2023 | −$500 |
| Net Income | Q3 2025 · Nov 30, 2023 | −$6.07K |
| Net Income | Q3 2025 · Aug 31, 2023 | −$3.82K |
| Net Income | Q3 2025 · May 31, 2023 | −$1.75K |
| Gross Profit | Q3 2025 · Nov 30, 2023 | $3.29K |
| Gross Profit | Q3 2025 · Nov 30, 2023 | $18.23K |